Conditions: Schizophrenia
Keywords: Schizophrenia SM-13496 Latuda Lurasidone
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 488
Healthy volunteers: no

Brief summary:
Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe as compared with quetiapine XR short term among acutely psychotic patients with chronic schizophrenia.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: Lurasidone intervention 2: Lurasidone intervention 3: Quetiapine XR intervention 4: Placebo
Intervention descriptions: intervention 1: Lurasidone 80 mg tablets intervention 2: Lurasidone 4 40 mg tablets intervention 3: Quetiapine XR 600mg intervention 4: Matching Placebo to Lurasidone or Quetiapine

Protocol document: